Search Results - "Pipek, Barbora"

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study by Mitrova, Katarina, Pipek, Barbora, Bortlik, Martin, Bouchner, Ludek, Brezina, Jan, Douda, Tomas, Drasar, Tomas, Drastich, Pavel, Falt, Premysl, Klvana, Pavel, Leksa, Vaclav, Novotny, Ales, Svoboda, Pavel, Skorpik, Jan, Ulbrych, Jan, Veinfurt, Marek, Zborilova, Blanka, Lukas, Milan, Duricova, Dana

“…Background: Vedolizumab demonstrated different placental pharmacokinetics than other immunoglobulin G1 antibodies, leading to lower drug levels in cord blood…”
Get full text

Administration of mucolytic solution before upper endoscopy - double-blind, monocentric, randomized study by Stepan, Michal, Falt, Premysl, Pipek, Barbora, Fojtik, Petr, Hanousek, Martin, Hill, Martin, Urban, Ondrej

“…Sufficient visibility of the mucosa during upper endoscopy is crucial for successful diagnosis, especially for early neoplastic lesions. Data documenting the…”
Get full text

Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort by Mitrova, Katarina, Cerna, Karin, Zdychyncova, Kristyna, Pipek, Barbora, Svikova, Jana, Minarikova, Petra, Adamcova, Miroslava, David, Jan, Lukas, Milan, Duricova, Dana

“…Evidence on serological responses to vaccination in children exposed to ustekinumab (UST) or vedolizumab (VDZ) in utero is lacking. This multicentre…”
Get full text

Sa1852 VEDOLIZUMAB DRUG LEVELS IN MATERNAL AND CORD BLOOD FOLLOWING TREATMENT OF INFLAMMATORY BOWEL DISEASE IN PREGNANCY: ONGOING MULTICENTRE PROSPECTIVE STUDY FROM THE CZECH REPUBLIC by Pipek, Barbora, Duricova, Dana, Mitrova, Katarina, Bortlik, Martin, urban, ondrej, Lukas, Milan

Get full text

Su1045 EFFICIENCY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF ILEOCOLONIC ANASTOMOTIC STRICTURES IN PATIENTS WITH CROHN'S DISEASE: A MULTICENTRIC RETROSPECTIVE STUDY by Lukas, Martin, Kolar, Martin, Vasatko, Martin, Klvana, Pavel, Leksa, Vaclav, Dyntr, Jiri, Baca, Lukas, Pipek, Barbora, Bahnikova, Barbora, Summerova, Sandra

Get full text

Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study by Mitrova, Katarina, Pipek, Barbora, Bortlik, Martin, Bouchner, Ludek, Brezina, Jan, Douda, Tomas, Drasar, Tomas, Klvana, Pavel, Kohout, Pavel, Leksa, Vaclav, Minarikova, Petra, Novotny, Ales, Svoboda, Pavel, Skorpik, Jan, Ulbrych, Jan, Veinfurt, Marek, Zborilova, Blanka, Lukas, Milan, Duricova, Dana

“…Evidence on the safety of newer biologics during pregnancy is limited. We aimed to assess the safety of ustekinumab and vedolizumab treatment during gestation…”
Get full text

Extraintestinal complications of inflammatory bowel diseases by Navrátil, Vít, Cveková, Silvia, Slodička, Peter, Aiglová, Květoslava, Pipek, Barbora, Falt, Přemysl

“…Inflammatory bowel disease (IBD) includes Crohns disease (CD) and ulcerative colitis (UC). Those are chronic gastrointestinal disorders of inflammatory nature…”
Get more information

The efficacy of treatment of local residual neoplasia under standardized conditions by Urban, Ondřej, Pipek, Barbora, Kajzrlíková, Ivana Mikoviny, Falt, Přemysl, Fojtík, Petr, Vítek, Petr

“…Piecemeal endoscopic mucosal resection (EMR) is frequently used for the treatment of non-poly-poid colorectal lesions larger than 20 mm. Nevertheless, local…”
Get more information